APLS - APLS INVESTOR ALERT: Bronstein Gewirtz & Grossman LLC Announces that Apellis Pharmaceuticals Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit | Benzinga
NEW YORK, Aug. 29, 2023 (GLOBE NEWSWIRE) -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Against Apellis Pharmaceuticals, Inc. ("Apellis" or the "Company") (NASDAQ:APLS) and certain of its officers.
Class Definition:
This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Apellis securities between January 28, 2021, and July 28, 2023, inclusive (the "Class Period"). Such investors are encouraged to join this case by visiting the firm's site: